Odyssey Therapeutics (NASDAQ:ODTX – Get Free Report) had its price objective lifted by JPMorgan Chase & Co. from $26.00 to $29.00 in a note issued to investors on Friday,Benzinga reports. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $33.00. Get Odyssey Therapeutics alerts:View Our Latest Stock Report on ODTXOdyssey Therapeutics Stock PerformanceShares of NASDAQ ODTX traded up $0.40 during mid-day trading on Friday, hitting $21.95. Odyssey Therapeutics has a 1 year low of $15.10 and a 1 year high of $22.26. Featured StoriesReceive News & Ratings for Odyssey Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.